Ependion AB
F:TW4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ependion AB
F:TW4
|
SE |
|
S
|
Sutro Biopharma Inc
F:S09
|
US |
|
G
|
Gilat Satellite Networks Ltd
XMUN:GSA
|
IL |
|
K
|
KKR Real Estate Finance Trust Inc
F:8KR
|
US |
|
J
|
Janus Henderson Group PLC
F:HDJA
|
UK |
Wall St Price Targets
TW4 Price Targets Summary
Ependion AB
According to Wall Street analysts, the average 1-year price target for TW4 is 11.32 EUR with a low forecast of 9.83 EUR and a high forecast of 12.77 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TW4's stock price target?
Price Target
11.32
EUR
According to Wall Street analysts, the average 1-year price target for TW4 is 11.32 EUR with a low forecast of 9.83 EUR and a high forecast of 12.77 EUR.
What is the Revenue forecast for Ependion AB?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Ependion AB?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for Ependion AB?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 22%.
What is the Pre-Tax Income forecast for Ependion AB?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 31%.
What is the Net Income forecast for Ependion AB?
Projected CAGR
33%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 33%.
